PanGen Biotech Inc. (KOSDAQ:222110)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,180.00
+130.00 (2.15%)
Last updated: Aug 6, 2025
2.15%
Market Cap82.99B
Revenue (ttm)14.64B
Net Income (ttm)1.61B
Shares Out13.49M
EPS (ttm)135.74
PE Ratio45.31
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,677
Average Volume52,900
Open6,050.00
Previous Close6,050.00
Day's Range5,920.00 - 6,270.00
52-Week Range3,750.00 - 7,770.00
Beta-0.06
RSI46.40
Earnings Daten/a

About Endeavor Group Holdings

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 222110
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.